Breaking News
0

Mallinckrodt (MNK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Mallinckrodt's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
18.68 -0.52    -2.71%
15:42:14 - Real-time CFD Data. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: IE00BBGT3753 
CUSIP: 00BBGT375
  • Volume: 2,099,422
  • Bid/Ask: 18.67 / 18.68
  • Day's Range: 18.27 - 19.51
Mallinckrodt 18.68 -0.52 -2.71%

MNK Overview

 
Information about the Mallinckrodt Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close19.23
Day's Range18.27 - 19.51
Revenue2.64B
Open19.1
52 wk Range11.65 - 36.65
EPS12.84
Volume2,099,422
Market Cap1.6B
Dividend (Yield)N/A (N/A)
Average Vol. (3m)2,256,076
P/E Ratio1.5
Beta1.72
1-Year Change - 17.81%
Shares Outstanding83,313,240
Next Earnings DateFeb 25, 2019
What is your sentiment on Mallinckrodt?
or
Vote to see community's results!

Mallinckrodt News


Mallinckrodt Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Sell Sell Strong Sell Strong Sell
Technical Indicators Strong Buy Strong Buy Strong Sell Strong Sell Strong Sell
Summary Strong Buy Neutral Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Harami Bullish 30 Current
Harami Cross 30 Current
Completed Patterns
Bullish Engulfing 1H 1 Dec 17, 2018 02:00PM
Three Inside Up 30 2 Dec 17, 2018 02:30PM
Three Black Crows 1W 3 Nov 25, 2018

Mallinckrodt Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NYSE 18.68 18.67 18.68 2,099,422 -2.71% USD 15:42:14  
  Berlin 16.200 16.200 16.300 0 -6.36% EUR 13:35:00  
  Stuttgart 17.900 23.600 24.400 0 0.00% EUR 14/12  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 163.40 168.35 163.15 -2.08 -1.26% 33.21M 15:42:13  
  Alphabet A 1,018.40 1,062.38 1,017.19 -33.30 -3.17% 1.51M 15:42:14  
  Facebook 139.32 144.91 138.42 -4.74 -3.29% 16.24M 15:42:16  
  Amazon.com 1,514.26 1,576.03 1,505.01 -77.65 -4.88% 7.43M 15:42:12  
  Tesla 346.77 365.66 345.34 -18.94 -5.18% 6.50M 15:42:12  
  Netflix 262.08 272.98 261.08 -4.76 -1.78% 8.46M 15:42:19  
  NVIDIA 143.16 148.14 141.24 -3.29 -2.25% 14.24M 15:42:14  
  Microsoft 102.00 105.80 101.84 -4.03 -3.80% 36.05M 15:42:19  
  Alibaba 142.73 147.94 142.24 -6.27 -4.21% 11.56M 15:42:08  
  J&J 128.52 131.65 126.83 -4.48 -3.37% 31.37M 15:42:17  

Mallinckrodt Company Profile

IndustryMajor Drugs
SectorHealthcare
Employees

3900

Equity Type

ORD

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MNK Comments

Write your thoughts about Mallinckrodt
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jeffrey Day
Jeffrey Day Nov 08, 2017 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It’s a buy at these levels, take it to 25
Reply
0 0
Norm Norm
Norm Norm Apr 13, 2016 11:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Easy money Citron wrong on this one and I believe Left has potentially opened himself up to a lawsuit by MNK.
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email